Article
[PDF] Branding the Cure: A consumer perspective on Corporate Social Responsibility, Drug Promotion and the Pharmaceutical Industry
Main findings: Limited transparency in reporting CSR information...New marketing tactics may not be to consumers’ benefit...Breaches of regulations and CSR codes occur with regular frequency showing weak industry self-regulation...Strong and effective CSR must support [the following rights:] the right to safety [,] the right to be informed [,] the right to satisfaction of basic needs [,] the right to education [,] the right to a healthy environment. [The companies studied included: Abbott, AstraZeneca, Almirall Prodesfarma, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson (J&J), Lilly (Eli), Lundbeck, Menarini, Merck Sharp Dohme, Novartis, Novo Nordisk [part of Novo Group], Nycomed, Orion Pharma, Pfizer, Roche, Sanofi-Aventi, Schering AG, Schering-Plough, Wyeth]